Description

GHRP-6 10MG

We provide GHRP-6 as a 10MG synthetic hexapeptide research compound with a stated 99.1% purity. Furthermore, GHRP-6 acts as a growth hormone-releasing peptide and research agonist of the growth hormone secretagogue receptor, GHS-R1a. Consequently, researchers have investigated its relationship with growth hormone secretion, hypothalamic-pituitary signaling, appetite-related pathways, and broader endocrine regulation.

GHRP-6 Key Attributes

• Brand: AvigenLab
• Product Name: GHRP-6
• Quantity: 10MG
• Stated Purity: 99.1%
• Molecular Type: Synthetic Hexapeptide
• Sequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂
• Sequence Length: 6 Amino Acids
• Molecular Formula: C₄₆H₅₆N₁₂O₆
• Molecular Weight: 873.0 g/mol
• CAS Number: 87616-84-0
• Product Format: Vial
• Classification: Research Use Only
• Human Use: Not For Human Use

GHRP-6 Product Overview

We provide GHRP-6 for research involving growth hormone secretagogue signaling, GHS-R1a activity, pituitary hormone release, neuroendocrine regulation, and metabolic research. Moreover, its defined hexapeptide structure gives researchers a clearly characterized molecular subject for investigating receptor-mediated signaling. PubChem identifies the sequence as H-D-Trp-Ala-Trp-D-Phe-Lys-NH₂ and reports a molecular weight of 873.0 g/mol.

Additionally, experimental research has examined GHRP-6 in relation to growth hormone secretion and the broader hypothalamic-pituitary axis. Therefore, the compound provides researchers with a useful experimental model for examining interactions between peptide signaling and endocrine responses.

Explore additional research materials through our Online Store.

GHRP-6 Product Identification

We identify GHRP-6 as a 10MG synthetic hexapeptide carrying a stated 99.1% purity designation. Accordingly, the product’s sequence, molecular formula, molecular weight, quantity, purity, and vial configuration provide clear reference points for laboratory inventory and product documentation.

Product Category

We classify the material within our research peptide collection for endocrinology, neuroendocrine signaling, and growth-hormone research. Furthermore, GHRP-6 belongs to the broader family of growth hormone-releasing peptides that researchers have investigated for their interactions with the growth hormone secretagogue receptor.

Moreover, research involving this receptor system has examined how synthetic secretagogues influence pulsatile growth hormone release and downstream endocrine signaling. Consequently, the compound remains relevant to experimental investigations involving receptor activity and pituitary physiology.

Scientific Characteristics

The molecular sequence of GHRP-6 contains six amino acids: His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂. In particular, the inclusion of D-amino-acid residues distinguishes its molecular structure from many naturally occurring peptide sequences. PubChem lists its molecular formula as C₄₆H₅₆N₁₂O₆ and its molecular weight as 873.0 g/mol.

Furthermore, the compound interacts with the growth hormone secretagogue receptor system. Meanwhile, researchers have investigated GHS-R signaling in relation to pituitary growth hormone secretion and other physiological pathways. Therefore, its molecular characteristics provide a defined foundation for receptor and endocrine research.

Research Applications

We position GHRP-6 for research involving GHS-R1a signaling, growth hormone secretion, hypothalamic-pituitary regulation, neuroendocrine pathways, appetite-related signaling, and metabolic physiology.

Additionally, research has established GHRP-6 as a synthetic growth hormone-releasing hexapeptide that acts on the pituitary to stimulate growth hormone release. Consequently, researchers can investigate receptor activation alongside downstream endocrine responses.

Likewise, the ghrelin receptor system participates in broader physiological signaling beyond growth hormone regulation. Nevertheless, individual experimental outcomes depend on the biological model, experimental conditions, concentration, and measured endpoint. Accordingly, researchers should evaluate findings within their specific experimental context.

Product Configuration

We provide the material in a 10MG vial carrying a stated 99.1% purity designation. Furthermore, the defined quantity, molecular identity, purity specification, and physical presentation create straightforward reference points for laboratory inventory.

Additionally, the vial configuration distinguishes this presentation from other research peptides and alternative product formats. Consequently, researchers can organize the material according to its product name, molecular characteristics, quantity, purity, and Research Use Only classification.

Product Features

The primary features include a 10MG quantity, 99.1% stated purity, six-amino-acid peptide structure, and clearly defined molecular sequence. Moreover, the product label communicates Not For Human Use | Research Use Only.

Furthermore, the scientific profile of GHRP-6 encompasses growth hormone secretagogue activity, GHS-R1a signaling, pituitary hormone release, and neuroendocrine research. As a result, the material provides a defined molecular subject for investigating interconnected endocrine pathways.

Product Specifications

The molecular sequence, formula, molecular weight, and CAS number correspond with the chemical identity documented by PubChem.

Intended Research Context

We identify the material as Research Use Only and Not For Human Use. Accordingly, our documentation focuses on laboratory investigation rather than therapeutic or consumer applications.

In particular, researchers can examine the compound within experimental systems involving GHS-R1a activity, pituitary growth hormone signaling, hypothalamic regulation, and neuroendocrine mechanisms. Furthermore, the established receptor relationship provides a foundation for investigating how synthetic secretagogues influence endocrine signaling.

Nevertheless, experimental findings do not automatically establish therapeutic outcomes. Therefore, we maintain a clear distinction between documented research observations and clinical claims.

Packaging Information

We present the product in a clearly labeled 10MG vial featuring our AvigenLab product presentation. The packaging identifies the compound, displays the 10MG quantity, communicates the stated 99.1% Purity, and identifies the material as Not For Human Use | Research Use Only.

Additionally, the vial format provides straightforward identification within our research catalog. Consequently, researchers can distinguish this presentation from other growth-hormone-related research compounds.

Regulatory Information

We classify the product as Research Use Only and maintain the Not For Human Use designation throughout our product documentation. Accordingly, scientific publications concerning GHRP-6 do not constitute regulatory approval for this specific AvigenLab presentation.

Moreover, published research describes biological activity within specific experimental systems rather than establishing a general therapeutic application. Consequently, we focus our documentation on molecular identity, research pathways, product specifications, and scientific characteristics without presenting experimental observations as established clinical outcomes.

Storage and Handling

We recommend following the storage and handling conditions specified in the applicable AvigenLab product documentation. Because peptide stability can depend on formulation, packaging, environmental exposure, and other product-specific variables, we avoid assigning unsupported storage parameters.

Furthermore, researchers should maintain appropriate laboratory handling practices and follow the product-specific documentation associated with the material. Consequently, this approach supports consistent laboratory management without introducing assumptions about conditions that may vary between formulations.

Market Availability

Our 10MG presentation provides a defined research peptide configuration within our product collection. The product quantity, stated purity, six-amino-acid sequence, vial format, molecular identity, and Research Use Only classification create clear reference points for laboratory inventory.

Moreover, GHRP-6 has an established research history within endocrinology and neuroendocrine science. Likewise, its relationship with GHS-R1a makes it relevant to investigations involving growth hormone secretion and receptor-mediated endocrine signaling.

Product Reference

Our GHRP-6 10MG presentation provides a defined synthetic hexapeptide with a stated 99.1% purity designation. We document the material according to its HWAWFK sequence, molecular characteristics, vial configuration, research applications, and Research Use Only classification.

Consequently, the product provides researchers with a clearly identified material for investigating GHS-R1a activity, growth hormone secretagogue signaling, pituitary regulation, hypothalamic-pituitary pathways, and related neuroendocrine mechanisms. Furthermore, its well-defined molecular structure and established research history provide a consistent reference point for laboratory investigations involving growth hormone-releasing peptide biology